CBD Life Sciences Inc. (CBDL) Secures Landmark Agreement with Bronx Powerhouse Dispensary Smoking Scholars
CBD Life Sciences (OTC:CBDL) has secured a strategic partnership with Smoking Scholars, a premier Bronx dispensary, marking a significant expansion into the New York cannabis market. The agreement includes an initial order of various CBD products including pain relief cream, massage oil, gummies, tea, and mushroom face cream.
The partnership emerged following CBDL's successful showcase at the NECANN New Jersey Conference and is expected to generate hundreds of thousands in revenue within 12 months. This move positions CBDL strategically in the New York market, where dispensary sales are projected to reach $4.4 billion by 2027. The company is actively pursuing additional partnerships across the Northeast region.
CBD Life Sciences (OTC:CBDL) ha assicurato una partnership strategica con Smoking Scholars, una delle principali dispensarie del Bronx, segnando una significativa espansione nel mercato della cannabis di New York. L'accordo prevede un ordine iniziale di vari prodotti CBD tra cui crema per il dolore, olio da massaggio, gummies, tè e crema viso ai funghi.
La partnership è nata dopo la presentazione di successo di CBDL al NECANN New Jersey Conference ed è prevista la generazione di centinaia di migliaia di dollari di reddito entro 12 mesi. Questa mossa posiziona CBDL in modo strategico nel mercato di New York, dove si prevede che le vendite nelle dispensaries raggiungeranno $4.4 miliardi entro il 2027. L'azienda sta attivamente perseguendo ulteriori partnership nell'area Nordeste.
CBD Life Sciences (OTC:CBDL) ha asegurado una asociación estratégica con , una dispensaria destacada del Bronx, marcando una expansión significativa en el mercado de cannabis de Nueva York. El acuerdo incluye un pedido inicial de varios productos con CBD, como crema para el alivio del dolor, aceite de masaje, gomitas, té y una crema facial de hongos.
La asociación surgió tras la exitosa exhibición de CBDL en la NECANN New Jersey Conference y se espera que genere cientos de miles de dólares en ingresos en 12 meses. Este movimiento posiciona a CBDL estratégicamente en el mercado de Nueva York, donde se prevé que las ventas de dispensaries alcancen $4.4 mil millones para 2027. La empresa está buscando activamente alianzas adicionales en la región noreste.
CBD Life Sciences (OTC:CBDL)가 Bronx의 선도적인 매장인 Smoking Scholars와 전략적 파트너십을 체결하여 뉴욕 주 대마초 시장으로의 확장을 크게 진행했습니다. 계약에는 통증 완화 크림, 마사지 오일, 구미, 차, 버섯 성분의 페이스 크림을 포함한 다양한 CBD 제품의 초기 주문이 포함됩니다.
파트너십은 CBDL이 NECANN New Jersey Conference에서 성공적으로 전시된 뒤 형성되었으며, 12개월 이내에 수십만 달러의 매출 창출이 기대됩니다. 이 움직임은 뉴욕 시장에서 CBDL을 전략적으로 위치시키며, 2027년까지 디스펜서 매출이 $4.4십억에 이를 것으로 예측됩니다. 회사는 북동부 지역에서 추가 파트너십을 적극 모색 중입니다.
CBD Life Sciences (OTC:CBDL) a scellé un partenariat stratégique avec Smoking Scholars, une dispensary de premier plan dans le Bronx, marquant une expansion significative sur le marché des cannabis de New York. L'accord prévoit une commande initiale de divers produits à base de CBD, notamment une crème analgésique, une huile de massage, des gummies, du thé et une crème faciale aux champignons.
Le partenariat est né après l'exposition réussie de CBDL à la NECANN New Jersey Conference et devrait générer des centaines de milliers de dollars de revenus en 12 mois. Cette initiative positionne CBDL de manière stratégique sur le marché new-yorkais, où les ventes de dispensaries devraient atteindre 4,4 milliards de dollars d'ici 2027. L'entreprise poursuit activement d'autres partenariats dans la région du Nord-Est.
CBD Life Sciences (OTC:CBDL) hat eine strategische Partnerschaft mit Smoking Scholars geschlossen, einer führenden Apotheke im Bronx, und markiert damit eine bedeutende Expansion in den New Yorker Cannabis-Markt. Die Vereinbarung umfasst eine Erstbestellung verschiedener CBD-Produkte, darunter Schmerzgel, Massageöl, Gummibärchen, Tee und eine Pilz-Gesichtscreme.
Die Partnerschaft entstand nach der erfolgreichen Vorstellung von CBDL bei der NECANN New Jersey Conference und soll innerhalb von 12 Monaten Hunderttausende von Einnahmen bringen. Diese Bewegung positioniert CBDL strategisch im Markt von New York, wo die Dispensary-Verkäufe bis 2027 voraussichtlich 4,4 Milliarden Dollar erreichen werden. Das Unternehmen ist aktiv auf der Suche nach weiteren Partnerschaften in der Northeast-Region.
CBD Life Sciences (OTC:CBDL) قد أبرمت شراكة استراتيجية مع Smoking Scholars، وهي صيدلية رائدة في بروكسل/بروكسن، ما يمثل توسعاً هاماً في سوق القنب بنيويورك. تتضمن الاتفاقية طلباً ابتدائياً من مجموعة منتجات CBD تشمل كريم لتخفيف الألم، زيت تدليك، حبوب مضغ، شاي وكريم وجه بفطر.
ظهرت الشراكة بعد العرض الناجح لشركة CBDL في مؤتمر NECANN New Jersey Conference ومن المتوقع أن تحقق مئات الآلاف من الدولارات من العائدات خلال 12 شهراً. هذه الخطوة تضع CBDL بشكل استراتيجي في سوق نيويورك، حيث من المتوقع أن تبلغ مبيعات الصيدليات 4.4 مليار دولار بحلول عام 2027. تسعى الشركة بنشاط لإقامة شراكات إضافية في منطقة الشمال الشرقي.
CBD Life Sciences (OTC:CBDL) 已与Smoking Scholars建立战略伙伴关系，该 Bronx 的一流药房，标志着其在纽约大麻市场上的重要扩张。协议包括初始订单的多种 CBD 产品，涵盖缓痛霜、按摩油、软糖、茶及蘑菇面部霜。
该伙伴关系是在 CBDL 于 NECANN New Jersey Conference 成功展示之后形成，预计在 12 个月内实现数十万美元的收入。此举在纽约市场形成了战略性定位，预计到 2027 年 dispensary 的销售将达到 $4.4B。公司正在积极寻求东北地区的更多伙伴关系。
- Initial order from Smoking Scholars expected to generate hundreds of thousands in revenue within 12 months
- Strategic entry into New York market with projected dispensary sales of $4.4B by 2027
- Multiple potential partnership deals in pipeline across Northeast region
- Global CBD market forecasted to grow at 31% CAGR through 2030
- Operating in highly competitive New York cannabis marketplace
- Success heavily dependent on performance of initial order and consumer demand
With New York dispensaries projected to surpass
SCOTTSDALE, AZ / ACCESS Newswire / September 30, 2025 / CBD Life Sciences Inc. (OTC:CBDL), through its operating subsidiary CBD Vault, today announced a game-changing client acquisition with Smoking Scholars, a premier dispensary located at 784 Allerton Ave in the Bronx, New York. This strategic agreement, finalized following CBDL's successful showcase at the NECANN New Jersey Conference, positions the Company to capture a powerful share of the booming New York cannabis and CBD marketplace.
Smoking Scholars is a multi-million-dollar enterprise with an elite client roster stretching across the United States. Their decision to bring CBD Vault into their packed product catalog is a resounding endorsement of CBDL's premium formulations and an entry point into one of the most competitive and rewarding markets in the nation.
Under the agreement, Smoking Scholars has placed a significant initial order featuring:
CBD Pain Relief Cream
CBD Massage Oil
Full Spectrum Gummies
CBD Infused Tea
Reishi Mushroom Face Cream
This order alone has the potential to generate hundreds of thousands in revenue within the next 12 months, with repeat orders expected as consumer demand for CBD wellness products accelerates. Importantly, this is just one of many dispensaries CBDL is securing as part of its rapid nationwide expansion.
Tapping Into One of America's Fastest-Growing Markets
New York's cannabis industry is undergoing explosive growth, with annual dispensary sales projected to exceed
"Securing a powerhouse partner like Smoking Scholars is a watershed moment for our Company," said Lisa Nelson, President & CEO of CBD Life Sciences Inc. "This agreement validates our products on a national scale and gives us a strategic foothold in one of the most high-value markets in the country. For our shareholders, this deal represents not just immediate revenue but the beginning of long-term exponential growth."
Building Momentum from NECANN
CBDL's presence at NECANN continues to pay dividends. In addition to the Smoking Scholars partnership, management is actively engaged with multiple high-profile dispensaries across the Northeast, creating a robust pipeline of potential deals. The Company anticipates announcing additional agreements in the near future, further expanding its footprint and accelerating revenues.
Positioned for Long-Term Growth
With a diverse portfolio spanning pain management, relaxation, and skincare, CBDL is uniquely positioned to meet surging consumer demand for CBD and mushroom wellness products. Analysts forecast the global CBD market to grow at a CAGR of over
About CBD Life Sciences Inc. (CBDL)
CBD Life Sciences Inc. is a publicly traded company (OTC:CBDL) specializing in high-quality cannabidiol (CBD) and mushroom wellness products. Through its wholly owned subsidiary CBD Vault, the Company offers a diverse range of formulations including tinctures, gummies, creams, topicals, teas, and functional mushroom blends. With a growing retail footprint and rapidly expanding wholesale partnerships, CBDL is committed to building shareholder value by capitalizing on the booming global wellness industry.
Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
Website: https://www.thecbdvault.com
IR Contact: cbdvaultaz@gmail.com
Stay Connected & Be the First to Try Our New Functional Mushroom Products!
Mushroom Madness Instagram: https://www.instagram.com/mushroom.madnessaz
Mushroom Madness Website: https://www.mushroommadness.shop
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
Contact Information
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720
SOURCE: CBD Life Sciences, Inc.
View the original press release on ACCESS Newswire
FAQ
What products will CBDL supply to Smoking Scholars dispensary?
How much revenue is expected from the Smoking Scholars partnership?
What is the projected size of New York's dispensary market by 2027?
What is the growth forecast for the global CBD market?
Where is Smoking Scholars dispensary located?
